Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Deferred Taxes (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Deferred Taxes for 15 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Deferred Taxes rose 132.26% to $2.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$7.2 million, a 177.7% decrease, with the full-year FY2024 number at -$6.7 million, down 145.33% from a year prior.
  • Deferred Taxes was $2.0 million for Q3 2025 at Usana Health Sciences, up from -$7.8 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $3.7 million in Q2 2022 to a low of -$10.5 million in Q3 2022.
  • A 5-year average of -$971588.2 and a median of $1.1 million in 2022 define the central range for Deferred Taxes.
  • Peak YoY movement for Deferred Taxes: surged 154.26% in 2023, then plummeted 283.59% in 2024.
  • Usana Health Sciences' Deferred Taxes stood at $3.0 million in 2021, then tumbled by 61.89% to $1.1 million in 2022, then grew by 29.89% to $1.5 million in 2023, then tumbled by 283.59% to -$2.7 million in 2024, then surged by 175.01% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Deferred Taxes are $2.0 million (Q3 2025), -$7.8 million (Q2 2025), and $1.4 million (Q1 2025).